Versor Investments LP boosted its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 65.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,548 shares of the electronics maker’s stock after purchasing an additional 8,944 shares during the quarter. Versor Investments LP’s holdings in Dolby Laboratories were worth $1,448,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Dolby Laboratories by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after acquiring an additional 203,411 shares during the last quarter. State Street Corp boosted its position in shares of Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after acquiring an additional 180,072 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares during the last quarter. First Trust Advisors LP boosted its position in shares of Dolby Laboratories by 22.7% during the 3rd quarter. First Trust Advisors LP now owns 1,518,657 shares of the electronics maker’s stock valued at $109,905,000 after acquiring an additional 281,214 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Dolby Laboratories by 8.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,149,927 shares of the electronics maker’s stock valued at $83,220,000 after acquiring an additional 87,202 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the company. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, April 27th. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Rosenblatt Securities restated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $90.75.
Dolby Laboratories Stock Down 0.9%
DLB stock opened at $57.64 on Tuesday. The business’s fifty day simple moving average is $61.96 and its two-hundred day simple moving average is $64.11. Dolby Laboratories has a twelve month low of $55.73 and a twelve month high of $78.28. The firm has a market cap of $5.45 billion, a price-to-earnings ratio of 22.78 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. During the same quarter last year, the firm posted $1.34 earnings per share. The business’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Research analysts expect that Dolby Laboratories will post 3.22 EPS for the current year.
Dolby Laboratories Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be paid a dividend of $0.36 per share. The ex-dividend date is Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.5%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.
Insider Activity
In other news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total transaction of $198,420.00. Following the transaction, the senior vice president owned 83,218 shares in the company, valued at approximately $5,504,038.52. This trade represents a 3.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP John D. Couling sold 7,666 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the transaction, the senior vice president owned 118,353 shares in the company, valued at approximately $6,811,215.15. This represents a 6.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 18,021 shares of company stock worth $1,090,741. Company insiders own 37.93% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
